Related Experiment Video

Updated: Mar 8, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K

RASSF4 Overexpression Inhibits the Proliferation, Invasion, EMT, and Wnt Signaling Pathway in Osteosarcoma Cells

Minglei Zhang1, Dapeng Wang2, Tongtong Zhu1

  • 1Department of Orthopaedics, ChinaJapan Union Hospital, Jilin UniversityChangchunP.R. China.

Oncology Research
|January 14, 2017
PubMed

Insights

Ras-association domain family member 4 (RASSF4) inhibits osteosarcoma progression. Overexpressing RASSF4 suppresses tumor cell proliferation, invasion, and epithelial-mesenchymal transition by impacting Wnt signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The Ras-association domain family 4 (RASSF4) gene is frequently inactivated in human cancers.
  • The specific role of RASSF4 in osteosarcoma pathogenesis is not well understood.
  • Osteosarcoma is a primary bone cancer with significant metastatic potential.

Purpose of the Study:

  • To investigate the expression levels of RASSF4 in osteosarcoma.
  • To determine the functional impact of RASSF4 on osteosarcoma cell behavior.
  • To elucidate the molecular mechanisms underlying RASSF4's effects in osteosarcoma.

Main Methods:

  • Quantitative analysis of RASSF4 expression in osteosarcoma tissues and cell lines.
  • Overexpression of RASSF4 in osteosarcoma cells.
  • Assessment of cell proliferation, migration, and invasion assays.
  • Evaluation of epithelial-mesenchymal transition (EMT) markers.
  • Western blot analysis to detect key protein expression (β-catenin, cyclin D1, c-Myc).

Main Results:

  • RASSF4 expression was significantly lower in osteosarcoma tissues and cells compared to normal controls.
  • RASSF4 overexpression markedly suppressed osteosarcoma cell proliferation, migration, and invasion.
  • RASSF4 induction inhibited the EMT process in osteosarcoma cells.
  • Overexpression of RASSF4 led to decreased protein levels of β-catenin, cyclin D1, and c-Myc.
  • These proteins are key components of the Wnt signaling pathway.

Conclusions:

  • RASSF4 functions as a tumor suppressor in osteosarcoma.
  • RASSF4 overexpression inhibits osteosarcoma cell growth, metastasis, and EMT.
  • The inhibitory effects are mediated, at least in part, through the downregulation of the Wnt signaling pathway.
  • RASSF4 represents a potential therapeutic target for osteosarcoma treatment.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K